91 results about "Immobilized Antibodies" patented technology

An electrochemical immunosensor system with reduced interference, comprising: a first immunosensor that generates an electrochemical signal based on the formation of a sandwich between an immobilized antibody, a target analyte and a labeled antibody, wherein a portion of the signal arises from non-specific binding of the labeled antibody in the region of the first immunosensor, and a second immunosensor that acts as an immuno-reference sensor and generates a signal that is the same as or predictably related to the degree of non-specific binding which occurs in the region of the first immunosensor, and has an immunocomplex between an immobilized antibody and an endogenous or exogenous protein that is in the sample and that is not the target analyte.

A method for determining a soluble human ST2 in a sample conveniently at a high sensitivity and an assay kit are provided. By an immunological method comprising a step for bringing a sample into contact with an immobilized antibody formed by binding to an insoluble support a first anti-human ST2 antibody which binds specifically to a non-denatured human ST2, a step for labelling a first reaction product generated in the previous step by reacting said first reaction product with a second anti-human ST2 antibody which binds specifically to a non-denatured human ST2 by recognizing a site different from the site on ST2 where said first anti-human ST2 antibody binds and which is labelled with a label, and a step for determining the amount of the label on said first reaction product which has been labelled, a soluble human ST2 in a sample is determined. In addition, a recombinant ST2 is employed as a standard to prepare a calibration curve, based on which the ST2 in a sample is quantified.

A simple easy to manufacture analytical device capable of performing membrane based immunoassays on batch of samples within 3 to 10 minutes wherein the method permits focused application of samples, costly labeled immunoassay and signal amplification reagents, said device includes an antibody-immobilized micro porous membrane, breadth corner layer of which is directly attached to a semi-rigid liquid-impervious body with water insoluble adhesive; absorbent body is provided separately and is not attached to analytical device during manufacture, absorbent body is wetted and is placed proximal to the lower surface of the membrane thereby forming networks of capillary channels with the absorbent body; flow of samples or reagents is always kept downwards and focused without application of any force to the absorbent body and the use of disposable adsorbent body permits stepwise addition of signal amplification reagents for ultra sensitive detection of diagnostically important molecules by visual examination of the membrane surface.

The method for measuring the concentration of the measuring object uses a sensor chip comprising an optical waveguide layer and an antibody immobilized layer formed on the surface of the optical waveguide layer, which comprises immobilizing the measuring object and an enzyme-labeled antibody labeled with a labeling enzyme on the antibody immobilized layer of the sensor chip having an immobilized antibody, producing a color-developing and precipitating enzyme reaction product by allowing to react a coloring reagent with the labeling enzyme on the antibody immobilized layer to precipitate the enzyme reaction product on the antibody immobilized layer, allowing to totally reflect a light impinged on the sensor chip from the outside at an interface between the optical waveguide layer and the antibody immobilized layer, and observing to a physical value of the totally reflected light.

As shown in FIG. 1, an immunochromatography test strip 10 of the present embodiment is made of a base material 11 which includes a sample introduction section 12, a labeling section 13 and an immobilization section 14. The base material 11 is made of a material that is capable of being impregnated with a solvent of a sample solution containing a detection target substance. The material allows migration of a solvent of a sample solution by capillary action. The sample introduction section 12 is a region where a sample solution containing a detection target substance is introduced (e.g., dripped). The sample introduction section 12 contains a metal salt supported thereon. The labeling section 13 contains a labeled antibody 15, which is labeled with a labeling substance, in a state such that the labeled antibody 15 can be eluted into the sample solution. The labeled antibody 15 used herein specifically binds to a detection target substance. The immobilization section 14 contains an immobilized antibody 16. The immobilized antibody 16 used herein specifically binds to the detection target substance.

The present invention relates to an immunological test kit and immunoassay using a first immobilized antibody having affinity for a specific antigen. The invention is characterized by a second and third antibody being specific for different determinants of the antigen and modified with cross-linkable oligonucleotides. For detection, the oligonucleotides are amplified, whereby only such oligonucleotides will be amplified which have been cross-linked to each other. In this way unspecific background is avoided and detection is possible down to single molecules.

The invention belongs to the technical field of bioanalysis and detection, and in particular relates to a circulating tumor cell (CTC) capturing chip as well as a manufacturing method and an application thereof. A nitrocellulose membrane is used as a main body of a CTC chip, an antibody is fixed by using the ultrastrong adsorption capacity of the nitrocellulose membrane for proteins, and further cancer cells in blood are specifically captured. Experiment results show that the CTC chip has very high capturing efficiency for non-small lung cancer cells NCI-H1650 and successfully separates and detects micro cancer cells in human whole blood. The CTC capturing chip is novel and convenient, practical and high-efficient and great in clinical popularization and application potentials.

The present invention relates to systems that utilize a combination of immunoassay and magnetic immunoassay techniques to detect an analyte within an extended range of specified concentrations. In particular, a device is provided for detecting an analyte in a biological sample. The device includes a first electrochemical sensor positioned on a substrate. The first electrochemical sensor includes an immobilized layer of antibody configured to bind to the analyte. The device further includes a second electrochemical sensor positioned adjacent to the first electrochemical sensor on the substrate, and a magnetic material that generates a magnetic field aligned with respect to the second electrochemical sensor. The magnetic field captures magnetic beads that have an immobilized layer of antibody configured to bind to the analyte, and concentrates the magnetic beads on or near a surface of the second electrochemical sensor.

The invention discloses a canine parvovirus colloidal gold immunochromatography test strip and a preparation method. The test strip comprises a sample absorbing area, a gold label probe area, an immobilized antibody area, a water absorbing area and a bottom plate, wherein the sample absorbing area, the gold label probe area, the immobilized antibody area and the water absorbing area are sequentially paved on the bottom plate and partially overlapped each other; the gold label probe area is coated with a colloidal gold labeled anti-canine parvovirus monoclonal antibody F1; the immobilized antibody area is sequentially provided with a test line and a control line, the test line is coated with an anti-canine parvovirus monoclonal antibody B6, and the control line is coated goat anti-mouse IgG (immunoglobulin G). According to the preparation method, a glass fiber membrane, a polyester membrane coated with the anti-canine parvovirus monoclonal antibody F1, a nitrocellulose membrane coated with the test line and the control line, and water absorbing filter paper are assembled onto a polyethylene plate to obtain the canine parvovirus colloidal gold immunochromatography test strip. The test strip is fast to test, high in accuracy rate, high in specificity, and simple and convenient to carry and operate.

The invention discloses a PCV2 antibody colloidal gold immunity chromatography detection test paper and a making method thereof. The test paper comprises a sample absorption zone, a colloidal-gold probe zone, an immobilized antibody zone, a water absorption zone and a support plate, and the sample absorption zone, the colloidal-gold probe zone, the immobilized antibody zone and the water absorption zone are laid on the support plate and sequentially partially overlap with each other; the sample absorption zone is coated with PCV2-Cap proteins; the colloidal-gold probe zone is coated with a colloidal-gold probe 1 and a colloidal-gold probe 2 which are colloidal-gold labeled PCV2 monoclonal antibody and rabbit IgG respectively; and the immobilized antibody zone is sequentially coated with a contrast line C1 coated goat anti-rabbit IgG antibody, a test line T coated goat anti-pig IgG antibody, a contrast line C2 coated goat anti-rabbit IgG antibody and a contrast line C3 coated goat anti-mouse IgG antibody. The test paper has the advantages of rapid detection, high accuracy, strong specificity, and convenient carrying and operation, and is used for determining the level of the PCV2 antibody according to the deepness of the color of the contrast line.

The invention relates to analytical chemistry and to quantitative immunochemical analysis, in particular, to a method for immunochemical quantitative detection of various biological toxins by using biological microchips. A biological microchip comprises an ordered array of three-dimensional hydrogel cells on a solid support, which are produced by a method of photo- or chemically induced polymerization and contain immobilized antibodies to various bacterial, plant and animal biotoxins, or biotoxins. The use of microchips makes it possible to analyze a sample simultaneously for the presence of several biotoxins. The proposed method for detecting biotoxins can be used in medicine, in food industry, and in environmental protection.

The invention relates to a microfluidic chip for detection of a tumor marker group; the microfluidic chip comprises a base plate and a cover plate positioned above the base plate; the cover plate is provided with a blood collecting microneedle array, and the interior of each blood collecting microneedle is provided with a microtube; the cover plate and the base plate are glued or are subjected to thermocompression bonding to form an overflow chamber, a sample introduction chamber, a reaction chamber, a capillary flow passage and a waste liquid chamber; the sample introduction chamber communicates with the reaction chamber in a vertical space; the sample introduction chamber is internally provided with water absorbent paper and filter paper; the reaction chamber is located below the filter paper, the reaction chamber is internally provided with a microcolumn array, the bottom surface of the reaction chamber and the surface of the microcolumn array are coated with labelled antibodies coupled with chromophoric groups; the bottom of a tail end region of the capillary flow channel is provided with a plurality of test strips and quality control strips printed with immobilized antibody reagents. The self-service detection is achieved, assistance of professional devices is not needed, and an examinee operates the device by self. The blood collecting volume is extremely low, and only a drop of fingertip blood is needed and can be used for detecting various tumor marker indexes at the same time.

A sample analysis device used to detect a level of exposure of organophosphorus within a sample comprising a sample collection pad, at least one conjugate zone comprising an anti-analyte antibody that is conjugated with a reporter label, and a control antibody that is conjugated with a reporter label, a blocking and/or test zone comprising an immobilized nanoparticle or other molecule that captures the Organophosphate-bound analyte, a second blocking and/or test zone comprising an immobilized antibody that binds to the unbound analyte and an optional third blocking and/or control zone comprising an immobilized antibody that binds to the control molecule wherein, when the analyte is bound by the Organophosphate in the sample it will bind to the first test line, and if the analyte is “free’ from the Organophosphate it will bind to the second test line, and the control antibody will bind to the control line.

The invention discloses a method for constructing an electrochemical luminescence sensor based on double amplification of perylenetetracarboxylic acid signals of a cobalt-based metal organic framework. According to the method, perylenetetracarboxylic acid PTCA is loaded on ZIF-67 as a luminous body to form PTCA(at)ZIF-67 as a signal probe, wherein the ZIF-67 is used as a reinforcing agent and cancatalyze S2O8 < 2-> to generate more SO4 <-> so that double amplification of signals is realized. Besides, heptapeptide HGC is introduced to fix the antibody so that the biological activity of the sensor is maintained, the incubation efficiency of the antibody is improved and the sensitivity of constructing the sensor is greatly improved. The beta-amyloid protein A beta with different concentrations can be combined with different amounts of secondary antibody markers Ab2-Au-PTCA (at) ZIF-67 so that the luminous intensity of the sensor is changed and the ultra-sensitive detection of the A betais realized.

The invention relates to an immunochip test method of staphylococcus enterotoxins (SEA and SEB) and fumonisin (AFB1), so as to realize the simultaneous test on the same chip. According to the invention, for the test of AFB1, the monoclonal antibody of AFB1 is immobilized on the surface of a piece of aldehyde glass and then added to the chip together with a complete antigen labeled by a certain amount of Cy3, and the technical research on the immunochip can be carried out by using a competition method. For the test of SEA and SEB, a double-antibody sandwich method is adopted and the optimization of experiment conditions is carried out; in the test, SEA and SEB are added to a reaction tank, SE which is not combined is washed off after reaction, and then a corresponding labeled antibody is added so as to form an immobilized antibody- objected to be determinand-labeled antibody sandwich structure, and the intensity of a fluorescence signal is increased with increase of the concentration of the objected to be determinand. The method disclosed by the invention is simple in operation, low in cost, sensitive and rapid, the result can be stably and reliably obtained, and the whole test process needs 1-2 hours. A new method for rapid test of various biotoxins is provided.

The present invention provides a double-anti-sandwich colloidal gold detection kit. A gold-labeled antibody blocking solution, a gold-labeled antibody dilution solution and an immobilized antibody dilution solution with specific components are used in the kit. According to the kit provided by the present invention, by using three reagents with specific components, the gold-labeled antibody and theimmobilized antibody in the original colloidal gold detection can be interchangeable; and when the three reagents are used, the detection sensitivity is increased or equivalent to the original colloidal gold detection result.

The present invention relates to biopolymer detection methods based on antigen-antibody interactions, wherein the methods show improved S/N ratios, improved detection sensitivities, and reduced detection times. The present invention also relates to application of these methods to biochips. The invention further relates to antibody fixation methods wherein antibody molecules are immobilized to amide group-containing gels, or amide group-containing gels on insoluble substances. Using such gels prevents the nonspecific adsorption of antibody-binding molecules. By embedding these antibody-binding molecules in such gels, their antibody-binding activity is prevented from deteriorating. The methods for detecting biopolymers by trapping target biopolymers to the substrate side, comprise the steps of: 1) placing target biopolymers, with probe biopolymers and beads that are identified by antibodies or address probe peptides or biopolymer address linkers attached to their surface, in a solution; 2) hybridizing the target biopolymers with the probe biopolymers; and 3) identifying the address linkers bound to a substrate by the address probe peptide or biopolymers or polyclonal antibody molecules through antigen-antibody interactions. The methods for immobilizing antibodies comprise the steps of: 1) applying an amide group-containing gel embedded with antibody-binding molecules on a substrate of an insoluble substance in two or three dimensions; and 2) attaching the base of the antibody molecules to antibody-binding molecules.